Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $36.3K |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | 0.0% |
| R&D | $1.4M | $2.5M | $2.4M | $5.0M | $8.7M | $5.9M | $903.9K | $925.5K |
| Operating income | −$4.7M | −$6.6M | −$10.1M | −$13.4M | −$14.7M | −$26.4M | −$15.6M | −$7.1M |
| EBITDA | −$3.6M | −$7.9M | −$9.5M | −$12.6M | −$13.7M | −$26.8M | $48.9K | $574.7K |
| Net income | −$5.9M | −$14.6M | −$11.1M | −$13.5M | −$15.2M | −$32.7M | −$18.1M | −$6.6M |
| Net margin | — | — | — | — | — | — | — | -18078.3% |
| EPS (diluted) | -6.16 | -22.43 | -10.44 | -8.77 | -6.77 | -5.90 | -5.33 | -4.16 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds AZRX.
No tracked institution reports a position in AZRX as of their last filing.
No one on the platform has traded AZRX yet.
| $0 |
| — |
| LSTALisata Therapeutics, Inc. | $3.37 | -0.62% | $31M | — |
| ONCOOnconetix, Inc. | $1.00 | +4.68% | $333695 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.